|
1
|
Negbenebor NA, Heath CR and Usatine RP:
Melasma. J Fam Pract. 72:133–137. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
de Abreu L, Ramos-E-Silva M, Quintella LP,
Buçard AM, Bravo BSF, de Almeida AM and Moreira ACMS: Dermoscopic
classification of melasma: Concordance study and correlation with
the melanophages count. J Cosmet Dermatol. 21:5887–5894.
2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Khunger N, Kandhari R, Singh A and Ramesh
V: A clinical, dermoscopic, histopathological and
immunohistochemical study of melasma and facial pigmentary
demarcation lines in the skin of color. Dermatol Ther.
33(e14515)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Goandal NF, Rungby J and Karmisholt KE:
The role of sex hormones in the pathogenesis of melasma. Ugeskr
Laeger. 184(V10210769)2022.PubMed/NCBI(In Danish).
|
|
5
|
Zhou Y, Zeng HL, Wen XY, Jiang L, Fu CH,
Hu YB, Lei XX, Zhang L, Yu X, Yang SY, et al: Selaginellin inhibits
melanogenesis via the MAPK signaling pathway. J Nat Prod.
85:838–845. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Filoni A, Mariano M and Cameli N: Melasma:
How hormones can modulate skin pigmentation. J Cosmet Dermatol.
18:458–463. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sarkar R, Ailawadi P and Garg S: Melasma
in Men: A review of clinical, etiological, and management issues. J
Clin Aesthet Dermatol. 11:53–59. 2018.PubMed/NCBI
|
|
8
|
Sarkar R, Jagadeesan S, Basavapura
Madegowda S, Verma S, Hassan I, Bhat Y, Minni K, Jha A, Das A, Jain
G, et al: Clinical and epidemiologic features of melasma: A
multicentric cross-sectional study from India. Int J Dermatol.
58:1305–1310. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kheradmand M, Afshari M, Damiani G,
Abediankenari S and Moosazadeh M: Melasma and thyroid disorders: A
systematic review and meta-analysis. Int J Dermatol. 58:1231–1238.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rostami Mogaddam M, Safavi Ardabili N,
Iranparvar Alamdari M, Maleki N and Aghabalaei Danesh M: Evaluation
of the serum zinc level in adult patients with melasma: Is there a
relationship with serum zinc deficiency and melasma? J Cosmet
Dermatol. 17:417–422. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nelson B, Sitohang IBS, Marissa M,
Indriatmi W and Wisnu W: A comparative study of melasma severity
after hyperthyroid therapy in hyperthyroid subjects with melasma.
Acta Dermatovenerol Alp Pannonica Adriat. 30:31–34. 2021.PubMed/NCBI
|
|
12
|
Sastrini Sekarnesia I, Sitohang IBS,
Agustin T, Wisnu W and Hoemardani ASD: A comparison of serum zinc
levels in melasma and non-melasma patients: A preliminary study of
thyroid dysfunction. Acta Dermatovenerol Alp Pannonica Adriat.
29:59–62. 2020.PubMed/NCBI
|
|
13
|
Ghassemi M, Hosseinchi S, Seirafianpour F,
Dodangeh M and Goodarzi A: Non-alcoholic fatty liver and lipid
profile status in patients with melasma: A case-control study. J
Cosmet Dermatol. 20:3656–3660. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nie Y and Jiang R: . The Effect of
ShuganJieyu Formula on Treating Female Melasma and Its Influence on
Sexual Hormone Levels. Journal of Dermatology and Venereology.
42:249–251. 2020.
|
|
15
|
Yu T, Feng Y, Yu H, et al: Therapeutic
Efficacy and Safety of Compound Muni Ziqi Granules in the Adjuvant
Treatment of Chloasma: A Systematic Review. J China Pharmacy.
29:405–409. 2018.
|
|
16
|
Kwon SH, Na JI, Choi JY and Park KC:
Melasma: Updates and perspectives. Exp Dermatol. 28:704–708.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fatima S, Braunberger T, Mohammad TF,
Kohli I and Hamzavi IH: The role of sunscreen in melasma and
postinflammatory hyperpigmentation. Indian J Dermatol. 65:5–10.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Eide MJ and Weinstock MA: Association of
UV index, latitude, and melanoma incidence in nonwhite
populations-US Surveillance, Epidemiology, and End Results (SEER)
Program, 1992 to 2001. Arch Dermatol. 141:477–481. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Singh G, Chatterjee M, Grewal R and Verma
R: Incidence and care of environmental dermatoses in the
high-altitude region of ladakh, India. Indian J Dermatol.
58:107–112. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Passeron T and Picardo M: Melasma, a
photoaging disorder. Pigment Cell Melanoma Res. 31:461–465.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Herraiz C, Garcia-Borron JC,
Jiménez-Cervantes C and Olivares C: MC1R signaling. Intracellular
partners and pathophysiological implications. Biochim Biophys Acta
Mol Basis Dis. 1863 (10 Pt A):2448–2461. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim M, Shibata T, Kwon S, Park TJ and Kang
HY: Ultraviolet-irradiated endothelial cells secrete stem cell
factor and induce epidermal pigmentation. Sci Rep.
8(4235)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Seo EY, Jin SP, Sohn KC, Park CH, Lee DH
and Chung JH: UCHL1 regulates melanogenesis through controlling
MITF stability in human melanocytes. J Invest Dermatol.
137:1757–1765. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xing X, Xu Z, Chen L, Jin S, Zhang C and
Xiang L: Tranexamic acid inhibits melanogenesis partially via
stimulation of TGF-β1 expression in human epidermal keratinocytes.
Exp Dermatol. 31:633–640. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kumaran MS, Narayan RV, Kaushik A, Bishnoi
A, Vinay K and Parsad D: Clinico-epidemiological profile and long
term follow up in melasma. Dermatol Ther. 34(e15143)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Holmo NF, Ramos GB, Salomão H, Werneck RI,
Mira MT, Miot LDB and Miot HA: Complex segregation analysis of
facial melasma in Brazil: Evidence for a genetic susceptibility
with a dominant pattern of segregation. Arch Dermatol Res.
310:827–831. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Desai S, Ayres E, Bak H, Manco M, Lynch S,
Raab S, Du A, Green D, Skobowiat C, Wangari-Talbot J and Zheng Q:
Effect of a tranexamic acid, kojic acid, and niacinamide containing
serum on facial dyschromia: A clinical evaluation. J Drugs
Dermatol. 18:454–459. 2019.PubMed/NCBI
|
|
28
|
Suryaningsih BE, Sadewa AH, Wirohadidjojo
YW and Soebono H: Association between heterozygote Val92Met MC1R
gene polymorphisms with incidence of melasma: A study of Javanese
women population in Yogyakarta. Clin Cosmet Investig Dermatol.
12:489–495. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Handa S, De D, Khullar G, Radotra BD and
Sachdeva N: The clinicoaetiological, hormonal and histopathological
characteristics of melasma in men. Clin Exp Dermatol. 43:36–41.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sun M, Xie HF, Tang Y, Lin SQ, Li JM, Sun
SN, Hu XL, Huang YX, Shi W and Jian D: G protein-coupled estrogen
receptor enhances melanogenesis via cAMP-protein kinase (PKA) by
upregulating microphthalmia-related transcription factor-tyrosinase
in melanoma. J Steroid Biochem Mol Biol. 165(Pt B):236–246.
2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Campuzano-García AE, Torres-Alvarez B,
Hernández-Blanco D, Fuentes-Ahumada C, Cortés-García JD and
Castanedo-Cázares JP: DNA methyltransferases in malar melasma and
their modification by sunscreen in combination with 4% Niacinamide,
0.05% Retinoic Acid, or Placebo. Biomed Res Int.
2019(9068314)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kim NH, Choi SH, Kim CH, Lee CH, Lee TR
and Lee AY: Reduced MiR-675 in exosome in H19 RNA-related
melanogenesis via MITF as a direct target. J Invest Dermatol.
134:1075–1082. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kim JY, Lee TR and Lee AY: Reduced WIF-1
expression stimulates skin hyperpigmentation in patients with
melasma. J Invest Dermatol. 133:191–200. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kim NH, Choi SH, Yi N, Lee TR and Lee AY:
Arginase-2, a miR-1299 target, enhances pigmentation in melasma by
reducing melanosome degradation via senescence-induced autophagy
inhibition. Pigment Cell Melanoma Res. 30:521–530. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Karami Fath M, Azami J, Masoudi A,
Mosaddeghi Heris R, Rahmani E, Alavi F, Alagheband Bahrami A,
Payandeh Z, Khalesi B, Dadkhah M, et al: Exosome-based strategies
for diagnosis and therapy of glioma cancer. Cancer Cell Int.
22(262)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kohli I, Chaowattanapanit S, Mohammad TF,
Nicholson CL, Fatima S, Jacobsen G, Kollias N, Lim HW and Hamzavi
IH: Synergistic effects of long-wavelength ultraviolet A1 and
visible light on pigmentation and erythema. Br J Dermatol.
178:1173–1180. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lim HW, Kohli I, Ruvolo E, Kolbe L and
Hamzavi IH: Impact of visible light on skin health: The role of
antioxidants and free radical quenchers in skin protection. J Am
Acad Dermatol. 86 (3S):S27–S37. 2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Babbush KM, Babbush RA and Khachemoune A:
The therapeutic use of antioxidants for melasma. J Drugs Dermatol.
19:788–792. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Handel AC, Miot LD and Miot HA: Melasma: A
clinical and epidemiological review. An Bras Dermatol. 89:771–782.
2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Katiyar S and Yadav D: Correlation of
oxidative stress with melasma: An overview. Curr Pharm Des.
28:225–231. 2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ogbechie-Godec OA and Elbuluk N: Melasma:
An up-to-date comprehensive review. Dermatol Ther (Heidelb).
7:305–318. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chun L: Clinical efficacy of glutathione
combined with vitamin C in the treatment of female chloasma and its
effect on estrogen and progesterone levels. J Contemporary
Medicine. 28:60–62. 2022.
|
|
43
|
Hu Y, Wang P and Han K: Hydrogen
attenuated inflammation response and oxidative in hypoxic ischemic
encephalopathy via Nrf2 mediated the inhibition of NLRP3 and NF-κB.
Neuroscience. 485:23–36. 2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhu Q, Wu Y, Li Y, Chen Z, Wang L, Xiong
H, Dai E, Wu J, Fan B, Ping L and Luo X: Positive effects of
hydrogen-water bathing in patients of psoriasis and parapsoriasis
en plaques. Sci Rep. 8(8051)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Chilicka K, Rogowska AM and Szyguła R:
Effects of topical hydrogen purification on skin parameters and
acne vulgaris in adult women. Healthcare (Basel).
9(144)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yoon YS, Sajo ME, Ignacio RM, Kim SK, Kim
CS and Lee KJ: Positive Effects of hydrogen water on
2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice.
Biol Pharm Bull. 37:1480–1485. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
He L: New ideas for the diagnosis and
treatment of melasma. J Dermatology and Venereology. 34:13–14.
2012.
|
|
48
|
Flori E, Mastrofrancesco A, Mosca S,
Ottaviani M, Briganti S, Cardinali G, Filoni A, Cameli N, Zaccarini
M, Zouboulis CC and Picardo M: Sebocytes contribute to melasma
onset. iScience. 25(103871)2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Kim M, Lee J, Park TJ and Kang HY:
Paracrine crosstalk between endothelial cells and melanocytes
through clusterin to inhibit pigmentation. Exp Dermatol. 27:98–100.
2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ayhan E: Intralesional tranexamic acid in
treatment of telangiectasia: Reversible effect and resistance to
therapy. Clin Exp Dermatol. 44:e209–e210. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Geddes ER, Stout AB and Friedman PM:
Retrospective analysis of the treatment of melasma lesions
exhibiting increased vascularity with the 595-nm pulsed dye laser
combined with the 1927-nm fractional low-powered diode laser.
Lasers Surg Med. 49:20–26. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Song T, Zhang X, Gao N, et al: Therapeutic
efficacy of intense pulsed light combined with Nd: YAG laser for
treatment of chloasma. Chinese Journal of Medical Physics.
38:1535–1537. 2021.
|
|
53
|
Espósito ACC, Brianezi G, de Souza NP,
Miot LDB, Marques MEA and Miot HA: Exploring pathways for sustained
melanogenesis in facial melasma: An immunofluorescence study. Int J
Cosmet Sci. 40:420–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Phansuk K, Vachiramon V, Jurairattanaporn
N, Chanprapaph K and Rattananukrom T: Dermal pathology in melasma:
An update review. Clin Cosmet Investig Dermatol. 15:11–19.
2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Espósito ACC, Brianezi G, de Souza NP,
Miot LDB and Miot HA: Exploratory study of epidermis, basement
membrane zone, upper dermis alterations and wnt pathway activation
in melasma compared to adjacent and retroauricular skin. Ann
Dermatol. 32:101–108. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Rodríguez-Arámbula A, Torres-Álvarez B,
Cortés-García D, Fuentes-Ahumada C and Castanedo-Cázares JP: CD4,
IL-17, and COX-2 Are associated with subclinical inflammation in
malar melasma. Am J Dermatopathol. 37:761–766. 2015.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Gautam M, Patil S, Nadkarni N, Sandhu M,
Godse K and Setia M: Histopathological comparison of lesional and
perilesional skin in melasma: A cross-sectional analysis. Indian J
Dermatol Venereol Leprol. 85:367–373. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Li Y, Yang CY, Man MQ, Gu H, Wu WJ, Tu Y,
Ding DM and He L: Disruption of epidermal permeability barrier
enhances UV-induced hyperpigmentation. Photodermatol Photoimmunol
Photomed. 36:156–158. 2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Sohn E: Skin microbiota's community
effort. Nature. 563:S91–S93. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Yan S: Skin Barrier and Melasma.
Dermatology Bulletin. 39:430–434. 2022.
|
|
61
|
Nofal A, Ibrahim AM, Nofal E, Gamal N and
Osman S: Topical silymarin versus hydroquinone in the treatment of
melasma: A comparative study. J Cosmet Dermatol. 18:263–270.
2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zou P, Du Y, Yang C and Cao Y: Trace
element zinc and skin disorders. Front Med (Lausanne).
9(1093868)2022.PubMed/NCBI View Article : Google Scholar
|
